Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Deferred Taxes: 2011-2018

Historic Deferred Taxes for Niagen Bioscience (NAGE) over the last 5 years, with Dec 2018 value amounting to -$16,000.

  • Niagen Bioscience's Deferred Taxes fell 100.00% to -$16,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $2,000, marking a year-over-year decrease of 98.89%. This contributed to the annual value of $2,000 for FY2018, which is 98.89% down from last year.
  • As of Q4 2018, Niagen Bioscience's Deferred Taxes stood at -$16,000, which was down 100.00% from -$8,000 recorded in Q3 2018.
  • Over the past 5 years, Niagen Bioscience's Deferred Taxes peaked at $321,037 during Q4 2016, and registered a low of -$50,000 during Q1 2018.
  • Over the past 3 years, Niagen Bioscience's median Deferred Taxes value was -$8,000 (recorded in 2018), while the average stood at $50,228.
  • Its Deferred Taxes has fluctuated over the past 5 years, first skyrocketed by 1,081.37% in 2016, then crashed by 225.00% in 2018.
  • Quarterly analysis of 3 years shows Niagen Bioscience's Deferred Taxes stood at $321,037 in 2016, then crashed by 102.49% to -$8,000 in 2017, then plummeted by 100.00% to -$16,000 in 2018.
  • Its last three reported values are -$16,000 in Q4 2018, -$8,000 for Q3 2018, and $76,000 during Q2 2018.